LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

LLY

762.79

+0.4%↑

JNJ

174.31

-1.4%↓

ABBV

221.87

+0.84%↑

UNH

334.97

-1.8%↓

AZN

77.08

-0.7%↓

Search

Kala Pharmaceuticals Inc

Closed

17.5 0.4

Overview

Share price change

24h

Current

Min

16.99

Max

17.83

Key metrics

By Trading Economics

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+36.46% upside

Dividends

By Dow Jones

Next Earnings

10 Nov 2025

Kala Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

18 Sept 2025, 23:56 UTC

Hot Stocks

Stocks to Watch: FedEx, 22nd Century, Scholastic

18 Sept 2025, 22:01 UTC

Major Market Movers

22nd Century Group Shares Gain on Debt Repayment, New Capital

18 Sept 2025, 20:51 UTC

Acquisitions, Mergers, Takeovers

UPS Terminates Plan to Buy Estafeta

18 Sept 2025, 20:31 UTC

Earnings

FedEx 1Q Profit, Sales Rise on Improvement in U.S. Shipping -- Update

18 Sept 2025, 20:26 UTC

Earnings

FedEx 1Q Profit, Sales Rise on Improvement in U.S. Shipping

18 Sept 2025, 23:43 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

18 Sept 2025, 23:43 UTC

Market Talk

Nikkei May Rise on U.S. Stock Gains, Weaker Yen -- Market Talk

18 Sept 2025, 23:43 UTC

Market Talk

Global Equities Roundup: Market Talk

18 Sept 2025, 23:40 UTC

Market Talk

Gold Edges Lower Amid Cautious Mood -- Market Talk

18 Sept 2025, 23:31 UTC

Market Talk

FedEx Says U.S. Demand Is Resilient -- Market Talk

18 Sept 2025, 22:03 UTC

Earnings

FedEx Expects Trade Environment to Create $1B Headwind in 2026, CFO Says

18 Sept 2025, 22:01 UTC

Earnings

FedEx CFO: Asia-to-U.S. Declines Drove $150M International Export Headwind

18 Sept 2025, 21:56 UTC

Earnings

Lennar Missed Revenue Estimates. The Stock Is Down. -- Barrons.com

18 Sept 2025, 21:54 UTC

Earnings

FedEx Focused on Demand From Southeast Asia, Europe Amid China Shipping Slowdown, Customer Chief Says

18 Sept 2025, 21:48 UTC

Earnings

FedEx International Export Volumes Declined, Especially on China-to-U.S. Lane, Exec Says

18 Sept 2025, 21:47 UTC

Earnings

FedEx Had 5% Increase in U.S. Domestic Average Daily Package Volume in 1Q, Customer Chief Says

18 Sept 2025, 21:17 UTC

Earnings

FedEx Profit, Sales Rise on Improvement in U.S. Shipping -- 2nd Update

18 Sept 2025, 21:07 UTC

Earnings

FedEx Earnings Were a Relief. The Stock Is Up. -- Barrons.com

18 Sept 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

18 Sept 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

18 Sept 2025, 20:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

18 Sept 2025, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

18 Sept 2025, 20:22 UTC

Acquisitions, Mergers, Takeovers

UPS Cites Inability of All Closing Conditions to Be Satisfied

18 Sept 2025, 20:22 UTC

Acquisitions, Mergers, Takeovers

United Parcel Service Terminates Plan to Buy Estafeta

18 Sept 2025, 20:20 UTC

Acquisitions, Mergers, Takeovers

Here's How Much the U.S. Has Made on Its Intel Stock Purchase -- Barrons.com

18 Sept 2025, 20:18 UTC

Earnings

Nucor Stock Falls After Earnings. Why Its Guidance Was Far Off Rival Steel Dynamics. -- Barrons.com

18 Sept 2025, 20:18 UTC

Earnings

Bullish Crushes Earnings. The Crypto Stock Pops. -- Barrons.com

18 Sept 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

18 Sept 2025, 20:07 UTC

Earnings

FedEx Earnings Were a Relief. The Stock Is Up. -- Barrons.com

18 Sept 2025, 20:03 UTC

Earnings

FedEx 1Q FedEx Freight Segment Revenue $2.26B >FDX

Peer Comparison

Price change

Kala Pharmaceuticals Inc Forecast

Price Target

By TipRanks

36.46% upside

12 Months Forecast

Average 25 USD  36.46%

High 35 USD

Low 12 USD

Based on 5 Wall Street analysts offering 12 month price targets forKala Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

5 ratings

5

Buy

0

Hold

0

Sell

Financials

$

About Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc
help-icon Live chat